HEARTERIX A cardiac magnetic resonance solution to deliver a fast, fully automated, and comprehensive diagnostic assessment and interpretation of the patient’s cardiovascular health
- Coordinator
- Universite De Bordeaux, France
- Runs
- 1 June 2026 to 30 November 2027
- Status
- Running
- EU funding
- €150k
- Total cost
- —
- Partners
- 1 organisations in 1 countries
- Type
- European Research Council grant
- Grant agreement
- 101292889
What the project is doing
In the project's own words, from its summary on CORDIS.
HEARTERIX aims to evaluate the technical, clinical, and commercial feasibility of an innovative ERC-based technology that combines advanced image processing, artificial intelligence, and cutting-edge magnetic resonance imaging (MRI) solutions to automate and expedite the analysis and diagnosis of cardiac diseases. This technology has the potential to transform the clinical management of cardiac diseases by enhancing decision-support accuracy and improving efficiency through automatization.
The goals of this project are to:✓ Technically and clinically validate the feasibility and cost-effectiveness of HEARTERIX as a fully automated cardiac MRI image-analysis and decision-support solution for cardiac patients;✓ Conduct a comprehensive intellectual property landscape analysis and establish freedom-to-operate;✓ Assess the commercial viability of HEARTERIX;✓ Develop a detailed business plan to guide the commercialisation of HEARTERIX.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universite De Bordeaux | Bordeaux | France | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI